Trump Strikes Drug Pricing Deals

The White House says nine more drugmakers joined Trump's push to lower prescription costs.

•Leans Right

Trump touts new agreements to lower drug prices

Trump Reaches Deals with Nine More Pharmaceutical Companies

Trump touts deals with nine more pharmaceutical companies - UPI.com

Articles

Sources

Analysis & opinion

The reporting

A neutral summary of the key facts most outlets agree on, drawn from reporting across the political spectrum.

President Donald Trump announced deals with nine more drugmakers—Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB—to cut prices under his most-favored-nation initiative. The White House said the additions bring the program to 26 companies covering 89% of the branded drug market. The voluntary agreements target discounted sales to state Medicaid programs and tie U.S. prices to the lowest prices paid in other developed countries. Trump projected more than $600 billion in savings, though drug-by-drug prices and discount terms have not been released.

Analysis & opinion

The arguments that emerged from this coverage — built only from the analysis and opinion pieces, never from straight reporting. Each dot is one article, placed by its outlet's bias — left to right. How to read our graphics →

The commentary is scattered.

weigh in — but each argues its own distinct claim, so no shared angle emerged. The other report the story straight.